Human resistance artery reactivity is altered by liver transplantation and treatment with cyclosporin A.
Potocnik
S J
SJ
Department of Surgery, Austin Hospital, University of Melbourne, Victoria, Australia.
Phillips
P A
PA
Hardy
K J
KJ
D000273:Adipose Tissue / Q000098:blood supply; D000804:Angiotensin II / Q000494:pharmacology; D001127:Arginine Vasopressin / Q000494:pharmacology; D001158:Arteries / Q000187:drug effects* / Q000503:physiopathology; D016572:Cyclosporine / Q000627:therapeutic use*; D006801:Humans; D066298:In Vitro Techniques; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000503:physiopathology; D009638:Norepinephrine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects*; D014661:Vasoconstriction / Q000187:drug effects*
D000804:Angiotensin II; D001127:Arginine Vasopressin; D010656:Phenylephrine; D016572:Cyclosporine; D009638:Norepinephrine